ADIPOQ and obesity disorder: PA improves hypothalamic inflammatory states by reducing obesity-associated pro-inflammatory mediators (e.g., free fatty acids, TNFα, adiponectin, and advanced glycation end-products), thereby restoring leptin sensitivity and decreasing food intake (52).